Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_assertion type Assertion NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_head.
- NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_assertion description "[These results strongly support the utilization of PI3K pathway inhibitors in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_provenance.
- NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_assertion evidence source_evidence_literature NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_provenance.
- NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_assertion SIO_000772 21563232 NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_provenance.
- NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_assertion wasDerivedFrom befree-2016 NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_provenance.
- NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_assertion wasGeneratedBy ECO_0000203 NP893454.RAmI-WKF_LITzkINfT5XgTu-E1L2P9hyKXIIlx663UXCU130_provenance.